Officer received an award of 808 WST derivative securities | OQRO Insider tradesWhy it stands out
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Mar 1, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Mar 3, 2026
OfficerGrant / award
Context
- Classification
grant award
Code A — grant or award
- Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0000105770-26-000033
- Filed / recorded
Mar 3, 2026, 4:22 PM UTCAdded to OQROOct 2, 2026, 12:29 PM UTC Data qualityVerified: identifiers matched exactly IssuerWEST PHARMACEUTICAL SERVICES INC Reporting personChad Winters Officer titleVP, Chief Accounting Officer SecurityStock Option (Right to Buy) TableDerivative (Table II) Transaction dateMar 1, 2026 Acquired / disposedAcquired (A) Footnotes from the filing
- The stock option vests in four equal annual installments beginning on March 1, 2027.
Around the same time
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.